FRANKLIN LAKES, N.J.,
April 4, 2017 /PRNewswire/ -- BD
(Becton, Dickinson and Company) (NYSE: BDX), a leading global
medical technology company, today announced it has completed the
acquisition of Israeli-based Caesarea Medical Electronics (CME), a
global infusion pump systems manufacturer. In March 2014, CareFusion Corp., which was acquired
by BD in 2015, had acquired a non-controlling, minority stake in
CME.
"Our relationship with BD has been very successful over the past
two years, and this is the next logical step to elevate our
infusion technologies," said Swi
Barak, founder of CME. "This transaction will create new
opportunities for our people and our technology that we wouldn't
have been able to achieve alone."
The acquisition of CME expands BD's infusion portfolio to
include ambulatory, home and specialty acute care infusion pumps.
CME designs, manufactures and markets a range of infusion and
syringe pumps as well as related accessories and disposable
administration sets for both homecare and hospital settings. CME
infusion pumps are known for their compact and highly portable
design, making them ideal for specialty applications such as IV and
epidural anesthesia and pain management, hospital and home
nutrition, among others.
"The integration of CME's technology into BD will strengthen our
strategy of reinventing medication management across the health
care continuum," said Mike Garrison,
vice president and general manager of worldwide Infusion Solutions
for BD. "The acquisition of CME advances our mission to provide
efficient end-to-end IV safety solutions across a broad journey of
care."
This transaction completes the acquisition of the remaining 60
percent of CME. CareFusion had initially acquired a non-controlling
40 percent stake of CME in 2014. Additional terms of the
transaction were not disclosed.
About BD
BD is a global medical technology company
that is advancing the world of health by improving medical
discovery, diagnostics and the delivery of care. BD leads in
patient and health care worker safety and the technologies that
enable medical research and clinical laboratories. The company
provides innovative solutions that help advance medical research
and genomics, enhance the diagnosis of infectious disease and
cancer, improve medication management, promote infection
prevention, equip surgical and interventional procedures, and
support the management of diabetes. The company partners with
organizations around the world to address some of the most
challenging global health issues. BD has more than 40,000
associates across 50 countries who work in close collaboration with
customers and partners to help enhance outcomes, lower health care
delivery costs, increase efficiencies, improve health care safety
and expand access to health. For more information on BD, please
visit bd.com.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/bd-completes-acquisition-of-caesarea-medical-electronics-300434078.html
SOURCE BD